🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are urged to message these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering products of uncertain source.

Some professionals said the demand for the experimental drug could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Removal

According to TikTok, the platform has taken down problematic content and prohibited associated hashtags and query recommendations. The organization stated it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at residence.

Within moments of entering one community, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Information and Pricing

Inside these communities, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may subject users to possibly significant medical dangers”.